Sonnet BioTherapeutics is no longer just a cancer drug developer. Its $888 million merger will place it among the largest HYPE holders, blurring the lines between traditional finance and decentralized protocols in a high-stakes treasury experiment. According to a July…
Related Posts
CoinEx exchange drained of $27M worth of crypto in suspected hack
A CoinEx hot wallet transferred $27 million of various tokens to a wallet with no previous history in…
Bybit: 89% of stolen $1.4B crypto still traceable post-hack
The lion’s share of the hacked Bybit funds is still traceable after the historic cybertheft, as blockchain investigators…
The machine economy: AI will benefit crypto, or break it | Opinion
The next test for crypto comes down to whether we can upgrade onchain infrastructure to capture the upside…